Significant increases seen especially among rural, White, and higher-income adolescents
Among U.S. veterans, rates highest for Blacks and Hispanics
No improvement seen in representation of Black patients after implementation of a 2015 FDA action plan to improve diversity
From 2007 to 2019, opioid-stimulant deaths among Black people increased at more than three times the rate of White people
Depression/anxiety problems increased for urban, racial- and ethnic-minority children during versus six months before the pandemic
Young and racial minority populations, those with low socioeconomic status more likely to have higher frequency use
In nationwide survey, a majority of U.S. breast oncologists report that Black women encounter more barriers to genetic counseling, testing
No significant change seen in overdose death rates overall from 2018 to 2019, but rate increased among non-Hispanic Blacks
Children from families with lower income and those from minority racial/ethnic groups also most likely to have COVID-19-related school closures